Most recently, Greig has worked with GlaxoSmithKline’ (GSK) Corporate Venture Group, SR One.
Greig has held senior leadership positions in GSK, Advanced Technologies, Rib-X Pharmaceuticals and Anaphore in the past.
Syntaxin CEO Melanie Lee said that Russell’s knowledge and experience, working with both big pharma companies and in supporting high growth emerging companies will be invaluable in maximising the potential of their technology platform.